AMRS - Amyris, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
5.37
-0.06 (-1.10%)
As of 9:59AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close5.43
Open5.40
Bid5.38 x 800
Ask5.39 x 1100
Day's Range5.30 - 5.40
52 Week Range1.86 - 7.30
Volume58,478
Avg. Volume660,680
Market Cap269.449M
Beta-2.21
PE Ratio (TTM)N/A
EPS (TTM)-3.68
Earnings DateAug 8, 2018 - Aug 13, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.50
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    Amyris Announces Signing of Major UCP in Porto/AICEP Consortium Project Agreement Valued at $50 Million

    Amyris, Inc. (AMRS), the industrial bioscience company, today announced that it has executed an agreement for a significant project consortium in Europe with the Universidade Católica Portuguesa (UCP) Porto Campus and AICEP Portugal Global (AICEP). UCP is a university system, including the leading biotech school in Portugal, and operates 15 research centers. AICEP is an independent public entity of the Government of Portugal, focused in encouraging the best foreign companies to invest in Portugal.

  • GlobeNewswire7 days ago

    Amyris Set to Join Russell Microcap® Index

    Amyris, Inc. (AMRS), the industrial bioscience company, today announced that it is set to join the Russell Microcap® Index at the conclusion of the Russell US Indexes annual reconstitution, effective after the US market opens on June 25, according to a preliminary list of additions posted June 8. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell US Indexes primarily by objective, market-capitalization rankings and style attributes.

  • Why Amyris (AMRS) Could Be Positioned for a Slump
    Zacks14 days ago

    Why Amyris (AMRS) Could Be Positioned for a Slump

    Amyris (AMRS) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.

  • New Strong Sell Stocks for June 4th
    Zacks14 days ago

    New Strong Sell Stocks for June 4th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • ACCESSWIRE18 days ago

    Today’s Free Research Reports Coverage on Axalta Coating Systems and Three More Specialty Chemicals Stocks

    LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want a free Stock Review on AXTA sign up now at www.wallstequities.com/registration. Lined up for evaluation this morning are these four stocks: Aemetis Inc. (NASDAQ: AMTX), Amyris Inc. (NASDAQ: AMRS), Axalta Coating Systems Ltd (NYSE: AXTA), and Ecolab Inc. (NYSE: ECL).

  • ACCESSWIRE26 days ago

    Free Research Report as LyondellBasell’s Revenue Grew 16%; Earnings Surged 57%

    LONDON, UK / ACCESSWIRE / May 23, 2018 / If you want access to our free earnings report on LyondellBasell Industries N.V. (NYSE: LYB) ("LyondellBasell"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=LYB. LyondellBasell posted its financial results for first quarter of fiscal year 2018 (Q1 FY18) on April 27, 2018. The multinational chemical Company surpassed analysts' estimates for revenue and earnings for Q1 FY18.

  • ACCESSWIRE27 days ago

    Blog Exposure - Novvi and Chevron Sign Agreement to Develop and Bring to Market New Renewable Base Oil Technologies

    LONDON, UK / ACCESSWIRE / May 22, 2018 / If you want access to our free research report on Amyris, Inc. (NASDAQ: AMRS), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=AMRS as the Company's latest news hit the wire. On May 18, 2018, the Company, which is an industrial bioscience organization, and Chevron Products Co. ("Chevron"), a division of Chevron U.S.A. Inc. (NYSE: CVX), together declared that Amyris' sustainable lubricants joint venture JV Company, Novvi, has entered into an agreement with Chevron to jointly develop and bring to market novel renewable base oil technologies.

  • GlobeNewswire28 days ago

    BioDisrupt, Amyris Annual Investor Conference Provides Close-up of Technology & Strategy

    Leading biotech firm Amyris, Inc. (AMRS), will host its annual investor conference, BioDisrupt, on May 22, 2018 at the company’s Emeryville headquarters. BioDisrupt gives industry participants and investors an opportunity to gain an up-close view of the company’s pioneering design and development platform for commercializing No Compromise™ molecules, as well as the strategy behind its very successful evolution to focus on high-margin Health and Beauty consumer products & ingredients. Amyris is now one of the fastest growing small-cap companies on NASDAQ and, with Biossance, it has the fastest growing skincare brand in the U.S. Its products include specialty chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals, providing pure and sustainable alternatives to petroleum, plant and animal-based products, with a No Compromise™ approach to cost, performance and availability.

  • GlobeNewswirelast month

    Amyris Sustainable Lubricants Joint Venture Company, Novvi, and Chevron Enter Agreement To Develop and Bring To Market New Renewable Base Oil Technologies

    Amyris, Inc. (AMRS), the industrial bioscience company, and Chevron Products Company, a division of Chevron U.S.A. Inc., today announced that Novvi LLC and Chevron have entered into an agreement to jointly develop and bring to market novel renewable base oil technologies. Novvi’s base oil products and technology are recognized by the global lubricant market to deliver sustainable, high-performance solutions in a range of lubricant applications. Since launching its first commercial production in 2014, Novvi has been steadily increasing its base oil production to keep up with robust and growing demand for a variety of automotive, marine and industrial applications.

  • Biossance Launches Mobile Interactive Clean Beauty Consumer Experience
    PR Newswirelast month

    Biossance Launches Mobile Interactive Clean Beauty Consumer Experience

    NEW YORK, May 17, 2018 /PRNewswire/ -- Biossance™, the consumer beauty brand from Amyris, Inc. (AMRS), continues to lead the clean beauty movement with the launch of its new decked-out Clean Beauty Bus, bringing clean skincare products to a wider audience of consumers seeking non-toxic products that meet their needs.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of AMRS earnings conference call or presentation 14-May-18 8:30pm GMT

    Q1 2018 Amyris Inc Earnings Call

  • GlobeNewswirelast month

    Amyris Continues Strong Momentum and Execution with 77% Revenue Growth and Exceeds Gross Margin Target

    Q1 2018 GAAP revenue of $23.0 million, compared with GAAP revenue of $13.0 million for Q1 2017, representing 77% growth over first quarter of 2017. Q1 2018 Non-GAAP gross margin of $19.0 million, or 83%, ...

  • ACCESSWIRElast month

    Amyris, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Amyris, Inc. (NASDAQ: AMRS ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 4:30 PM Eastern Time. To listen ...

  • Is Amyris Inc’s (NASDAQ:AMRS) CEO Paid At A Competitive Rate?
    Simply Wall St.last month

    Is Amyris Inc’s (NASDAQ:AMRS) CEO Paid At A Competitive Rate?

    John Melo is the CEO of Amyris Inc (NASDAQ:AMRS), which has recently grown to a market capitalization of US$290.22M. Recognizing whether CEO incentives are aligned with shareholders is a crucialRead More...

  • GlobeNewswirelast month

    Amyris to Participate in Upcoming Investor Conferences

    EMERYVILLE, Calif., May 10, 2018-- Amyris, Inc., the industrial bioscience company, today announced that it plans to participate in the following upcoming investor conferences in May 2018.. Oppenheimer ...

  • GlobeNewswirelast month

    Amyris Presents Its No Compromise™ Product Portfolio at Techonomy New York

    Amyris, Inc. (AMRS), the industrial bioscience company, will be presenting its portfolio of commercialized products at Techonomy New York this morning. Amyris has enjoyed the benefit of successfully commercializing more than 10 products since 2012 that have all achieved strong commercial success and will be presenting this track record and its technology platform at this event. Amyris’s combination of No Compromise™ product sales and a value share/royalty business model is delivering strong gross margin performance.

  • Future Outlook Of The Energy Industry And Amyris Inc (NASDAQ:AMRS)
    Simply Wall St.last month

    Future Outlook Of The Energy Industry And Amyris Inc (NASDAQ:AMRS)

    Amyris Inc (NASDAQ:AMRS), a US$334.45M small-cap, is an oil and gas company operating in an industry which has seen a continued decline in oil prices since 2014. However, energy-sector analystsRead More...

  • GlobeNewswirelast month

    Amyris to Announce First Quarter 2018 Financial Results on Monday, May 14, 2018

    EMERYVILLE, Calif., May 08, 2018-- Amyris, Inc. will report financial results for the first quarter ended March 31, 2018 after market close on Monday, May 14, 2018.. The company will hold its quarterly ...

  • This Biotech Stock is Up 80% in 2018, but Is Its Business Model Sound?
    Motley Foollast month

    This Biotech Stock is Up 80% in 2018, but Is Its Business Model Sound?

    Amyris stock has finally gained some traction after years of struggling, but investors should beware of several notable red flags.

  • GlobeNewswire2 months ago

    Amyris Collaborates with Firmenich to Develop Disruptive Bio-Based Fragrance Ingredient

    Amyris, Inc. (AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner, Firmenich, to support the development and commercialization of Z11. “We are pleased with our ability to support Firmenich’s product innovation as they continue to be a leader in developing game-changing ingredients for their customers,” said John Melo, President & CEO of Amyris.

  • Who Really Owns Amyris Inc (NASDAQ:AMRS)?
    Simply Wall St.2 months ago

    Who Really Owns Amyris Inc (NASDAQ:AMRS)?

    Today, I will be analyzing Amyris Inc’s (NASDAQ:AMRS) recent ownership structure, an important but not-so-popular subject among individual investors. Ownership structure of a company has been found to affect shareRead More...

  • Options Traders Expect Huge Moves in Amyris (AMRS) Stock
    Zacks2 months ago

    Options Traders Expect Huge Moves in Amyris (AMRS) Stock

    Surging implied volatility makes Amyris (AMRS) stock lucrative to the option traders.

  • GlobeNewswire2 months ago

    Amyris to Present at H.C. Wainwright Global Life Sciences Investment Conference on April 9, 2018

    EMERYVILLE, Calif., April 03, 2018-- Amyris, Inc., the industrial bioscience company, today announced that management will be presenting at the H.C. Wainwright Global Life Sciences Investment Conference ...

  • ACCESSWIRE3 months ago

    Free Post Earnings Research Report: Chemours’ Quarterly Sales Jumped 19%; Turned Profitable Y-o-Y

    Stock Monitor: Amyris Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 23, 2018 / Active-Investors.com has just released a free earnings report on The Chemours Co. (NYSE: CC ). If you want access ...

  • Amyris (AMRS) Soars: Stock Adds 14.7% in Session
    Zacks3 months ago

    Amyris (AMRS) Soars: Stock Adds 14.7% in Session

    Amyris (AMRS) was a big mover last session, as the company saw its shares rise more than 14% on Friday amid huge volumes.